(Q37964754)

26 August 2017

Inflammation-mediated changes in drug transporter expression/activity: implications for therapeutic drug response (English)

1 reference

26 August 2017

0 references

Alexander M Cressman

1

1 reference

26 August 2017

Vanja Petrovic

series ordinal

2

1 reference

26 August 2017

Micheline Piquette-Miller

series ordinal

3

1 reference

26 August 2017

language of work or name

English

0 references

publication date

1 January 2012

1 reference

Expert Review of Clinical Pharmacology

26 August 2017

1 reference

26 August 2017

5

1 reference

26 August 2017

1

1 reference

26 August 2017

69-89

1 reference

Acute-phase proteins and other systemic responses to inflammation

26 August 2017

1 reference

The hypothalamic-pituitary-adrenal axis and immune-mediated inflammation

21 January 2018

1 reference

Hepatitis B Virus Infection

21 January 2018

1 reference

Immunological processes in malaria pathogenesis.

21 January 2018

1 reference

Effects of chronic renal failure on liver drug transporters

21 January 2018

1 reference

21 January 2018

1 reference

Inflammatory links between obesity and metabolic disease

21 January 2018

1 reference

Type 2 diabetes as an inflammatory disease

21 January 2018

1 reference

Inflammatory response: an unrecognised source of variability in the pharmacokinetics and pharmacodynamics of cancer chemotherapy

21 January 2018

1 reference

Study of the molecular mechanism of decreased liver synthesis of albumin in inflammation

21 January 2018

1 reference

Serum albumin: relationship to inflammation and nutrition

21 January 2018

1 reference

Impact of infectious and inflammatory disease on cytochrome P450-mediated drug metabolism and pharmacokinetics

21 January 2018

1 reference

Membrane transporters in drug development

21 January 2018

1 reference

Xenobiotic, bile acid, and cholesterol transporters: function and regulation.

21 January 2018

1 reference

Xenobiotic transporters: ascribing function from gene knockout and mutation studies

21 January 2018

1 reference

Regulation of drug transporters during infection and inflammation.

21 January 2018

1 reference

A family of drug transporters: the multidrug resistance-associated proteins.

21 January 2018

1 reference

Structural biology. The xyz of ABC transporters

21 January 2018

1 reference

Effects of interferon-inducing agents on hepatic cytochrome P-450 drug metabolizing systems

21 January 2018

1 reference

An inventory of the human ABC proteins

21 January 2018

1 reference

The human ATP-binding cassette (ABC) transporter superfamily

21 January 2018

1 reference

Expression of the multidrug resistance gene product (P-glycoprotein) in human normal and tumor tissues.

21 January 2018

1 reference

P-glycoprotein in autoimmune diseases

21 January 2018

1 reference

Expression levels of MDR1, MRP1, MRP4, and MRP5 in peripheral blood mononuclear cells from HIV infected patients failing antiretroviral therapy

21 January 2018

1 reference

Role of transport proteins in drug absorption, distribution and excretion

21 January 2018

1 reference

Role of P-glycoprotein in drug disposition

21 January 2018

1 reference

Multidrug resistance proteins (MRPs, ABCCs): importance for pathophysiology and drug therapy

21 January 2018

1 reference

Reconstitution of ATP-dependent leukotriene C4 transport by Co-expression of both half-molecules of human multidrug resistance protein in insect cells.

21 January 2018

1 reference

ABC efflux pump-based resistance to chemotherapy drugs.

21 January 2018

1 reference

Decreased expression of an ATP-binding cassette transporter, MRP2, in human livers with hepatitis C virus infection

21 January 2018

1 reference

MRP2 and 3 in health and disease

21 January 2018

1 reference

Functional characterization of the human multidrug transporter, ABCG2, expressed in insect cells

21 January 2018

1 reference

In vitro and in vivo evidence for the importance of breast cancer resistance protein transporters (BCRP/MXR/ABCP/ABCG2).

21 January 2018

1 reference

Real-time reverse transcription-PCR expression profiling of the complete human ATP-binding cassette transporter superfamily in various tissues.

21 January 2018

1 reference

Pharmacokinetic resistance to imatinib mesylate: role of the ABC drug pumps ABCG2 (BCRP) and ABCB1 (MDR1) in the oral bioavailability of imatinib

21 January 2018

1 reference

Mechanisms of biliary lipid secretion and their role in lipid homeostasis

21 January 2018

1 reference

Regurgitation of bile acids from leaky bile ducts causes sclerosing cholangitis in Mdr2 (Abcb4) knockout mice

21 January 2018

1 reference

Liver disease associated with canalicular transport defects: current and future therapies

21 January 2018

1 reference

The ABCs of solute carriers: physiological, pathological and therapeutic implications of human membrane transport proteinsIntroduction

21 January 2018

1 reference

Uptake transporters of the human OATP family: molecular characteristics, substrates, their role in drug-drug interactions, and functional consequences of polymorphisms

21 January 2018

1 reference

Hepatic OATP and OCT uptake transporters: their role for drug-drug interactions and pharmacogenetic aspects

21 January 2018

1 reference

Impact of OATP transporters on pharmacokinetics

21 January 2018

1 reference

In vitro and in vivo evidence of the importance of organic anion transporters (OATs) in drug therapy

21 January 2018

1 reference

Organic anion transporting polypeptides (OATPs): regulation of expression and function.

21 January 2018

1 reference

Mechanisms of pH-gradient driven transport mediated by organic anion polypeptide transporters

21 January 2018

1 reference

Role of organic cation transporters in the renal handling of therapeutic agents and xenobiotics

21 January 2018

1 reference

Drug and toxicant handling by the OAT organic anion transporters in the kidney and other tissues

21 January 2018

1 reference

Organic anion transporters of the SLC22 family: biopharmaceutical, physiological, and pathological roles

21 January 2018

1 reference

Organic cation transporters (OCTs, MATEs), in vitro and in vivo evidence for the importance in drug therapy

21 January 2018

1 reference

Role of organic cation transporters in drug-induced toxicity

21 January 2018

1 reference

The viral mimic, polyinosinic:polycytidylic acid, induces fever in rats via an interleukin-1-dependent mechanism.

21 January 2018

1 reference

Alteration of drug biotransformation and elimination during infection and inflammation

21 January 2018

1 reference

Endotoxin depresses hepatic cytochrome P450-mediated drug metabolism in women

21 January 2018

1 reference

Endotoxin administration to humans inhibits hepatic cytochrome P450-mediated drug metabolism

21 January 2018

1 reference

The effect of high dose endotoxin on CYP3A2 expression in the rat.

21 January 2018

1 reference

Decreased expression and activity of P-glycoprotein in rat liver during acute inflammation.

21 January 2018

1 reference

Inflammation and interleukin-6 mediate reductions in the hepatic expression and transcription of the mdr1a and mdr1b Genes.

21 January 2018

1 reference

Lipopolysaccharide-mediated regulation of hepatic transporter mRNA levels in rats

21 January 2018

1 reference

Regulation of the hepatic multidrug resistance gene expression by endotoxin and inflammatory cytokines in mice.

21 January 2018

1 reference

Up-regulation of the multidrug resistance genes, Mrp1 and Mdr1b, and down-regulation of the organic anion transporter, Mrp2, and the bile salt transporter, Spgp, in endotoxemic rat liver

21 January 2018

1 reference

Downregulation of mdr1a expression in the brain and liver during CNS inflammation alters the in vivo disposition of digoxin.

21 January 2018

1 reference

Impact of endotoxin-induced changes in P-glycoprotein expression on disposition of doxorubicin in mice.

21 January 2018

1 reference

Shiga-Like Toxin II Impairs Hepatobiliary Transport of Doxorubicin in Rats by Down-Regulation of Hepatic P Glycoprotein and Multidrug Resistance-Associated Protein Mrp2

21 January 2018

1 reference

Role of tumor necrosis factor-alpha in down-regulation of hepatic cytochrome P450 and P-glycoprotein by endotoxin

21 January 2018

1 reference

Suppression of drug-metabolizing enzymes and efflux transporters in the intestine of endotoxin-treated rats

21 January 2018

1 reference

Decreased P-glycoprotein (P-gp/MDR1) expression in inflamed human intestinal epithelium is independent of PXR protein levels

21 January 2018

1 reference

Effect of tumor necrosis factor-alpha and interferon-gamma on intestinal P-glycoprotein expression, activity, and localization in Caco-2 cells

21 January 2018

1 reference

Effect of endotoxin on doxorubicin transport across blood-brain barrier and P-glycoprotein function in mice

21 January 2018

1 reference

HIV-1 viral envelope glycoprotein gp120 triggers an inflammatory response in cultured rat astrocytes and regulates the functional expression of P-glycoprotein

21 January 2018

1 reference

Regulation of BCRP (ABCG2) and P-glycoprotein (ABCB1) by cytokines in a model of the human blood-brain barrier

21 January 2018

1 reference

Effect of endotoxin on P-glycoprotein-mediated biliary and renal excretion of rhodamine-123 in rats

21 January 2018

1 reference

Nitric oxide differentially regulates renal ATP-binding cassette transporters during endotoxemia

21 January 2018

1 reference

Lipopolysaccharide treatment downregulates the expression of the pregnane X receptor, cyp3a11 and mdr1a genes in mouse placenta

21 January 2018

1 reference

Effect of endotoxin on the expression of placental drug transporters and glyburide disposition in pregnant rats

21 January 2018

1 reference

Impact of polyinosinic/polycytidylic acid on placental and hepatobiliary drug transporters in pregnant rats.

21 January 2018

1 reference

ATP-binding cassette transporter expression in human placenta as a function of pregnancy condition.

21 January 2018

1 reference

Regulation of drug transporter expression in human hepatocytes exposed to the proinflammatory cytokines tumor necrosis factor-alpha or interleukin-6.

21 January 2018

1 reference

Regulation of drug transporter mRNA expression by interferon-γ in primary human hepatocytes

21 January 2018

1 reference

Regulation of major efflux transporters under inflammatory conditions at the blood-brain barrier in vitro

21 January 2018

1 reference

Inflammatory cytokines, but not bile acids, regulate expression of murine hepatic anion transporters in endotoxemia.

21 January 2018

1 reference

Endotoxin downregulates hepatic expression of P-glycoprotein and MRP2 in 2-acetylaminofluorene-treated rats

21 January 2018

1 reference

Regulation of MRP2/ABCC2 and BSEP/ABCB11 expression in sandwich cultured human and rat hepatocytes exposed to inflammatory cytokines TNF-{alpha}, IL-6, and IL-1{beta}

21 January 2018

1 reference

Down-regulation of organic anion transporter expression in human hepatocytes exposed to the proinflammatory cytokine interleukin 1beta

21 January 2018

1 reference

Up-regulation of basolateral multidrug resistance protein 3 (Mrp3) in cholestatic rat liver.

21 January 2018

1 reference

Regulation of human hepatic drug transporter expression by pro-inflammatory cytokines

21 January 2018

1 reference

Pharmacokinetics of fexofenadine following LPS administration to rats.

21 January 2018

1 reference

Estimates of the prevalence of arthritis and other rheumatic conditions in the United States. Part II

21 January 2018

1 reference

Estimates of the prevalence of arthritis and other rheumatic conditions in the United States. Part I.

21 January 2018

1 reference

Cytokine pathways and joint inflammation in rheumatoid arthritis

21 January 2018

1 reference

Epidemiology of CVD in rheumatic disease, with a focus on RA and SLE.

21 January 2018

1 reference

Drug Insight: resistance to methotrexate and other disease-modifying antirheumatic drugs--from bench to bedside

21 January 2018

1 reference

Anti-tumor necrosis factor ameliorates joint disease in murine collagen-induced arthritis

21 January 2018

1 reference

Hepatic pharmacokinetics of propranolol in rats with adjuvant-induced systemic inflammation

21 January 2018

1 reference

Effect of sinomenine on cytokine expression of macrophages and synoviocytes in adjuvant arthritis rats

21 January 2018

1 reference

Effect of early phase adjuvant arthritis on hepatic P450 enzymes and pharmacokinetics of verapamil: an alternative approach to the use of an animal model of inflammation for pharmacokinetic studies

21 January 2018

1 reference

Tissue-specific regulation of expression and activity of P-glycoprotein in adjuvant arthritis rats

21 January 2018

1 reference

Changes in mRNA expression of ABC and SLC transporters in liver and intestines of the adjuvant-induced arthritis rat.

21 January 2018

1 reference

Decreased intestinal CYP3A and P-glycoprotein activities in rats with adjuvant arthritis.

21 January 2018

1 reference

Effects of alterations in CAR on bilirubin detoxification in mouse collagen-induced arthritis.

21 January 2018

1 reference

Decreased PXR and CAR inhibit transporter and CYP mRNA Levels in the liver and intestine of mice with collagen-induced arthritis.

21 January 2018

1 reference

Decreased dromotropic response to verapamil despite pronounced increased drug concentration in rheumatoid arthritis

21 January 2018

1 reference

Inflammatory bowel disease

21 January 2018

1 reference

The immunological and genetic basis of inflammatory bowel disease

21 January 2018

1 reference

Temporal and spatial analysis of clinical and molecular parameters in dextran sodium sulfate induced colitis

21 January 2018

1 reference

Quantitative measurement of cytokine mRNA in inflammatory bowel disease: relation to clinical and endoscopic activity and outcome

21 January 2018

1 reference

21 January 2018

1 reference

Epidemiology and natural history of inflammatory bowel diseases

21 January 2018

1 reference

Molecular basis of epithelial barrier regulation: from basic mechanisms to clinical application

21 January 2018

1 reference

ABC of oral bioavailability: transporters as gatekeepers in the gut.

21 January 2018

1 reference

Closing the gaps: a full scan of the intestinal expression of p-glycoprotein, breast cancer resistance protein, and multidrug resistance-associated protein 2 in male and female rats

21 January 2018

1 reference

Region-dependent modulation of intestinal permeability by drug efflux transporters: in vitro studies in mdr1a(-/-) mouse intestine

21 January 2018

1 reference

Plasma levels of propranolol in treated patients with coeliac disease and patients with Crohn's disease.

21 January 2018

1 reference

Loss of detoxification in inflammatory bowel disease: dysregulation of pregnane X receptor target genes.

21 January 2018

1 reference

Altered expression and function of P-glycoprotein in dextran sodium sulfate-induced colitis in mice.

21 January 2018

1 reference

Global gene expression analysis of the mouse colonic mucosa treated with azoxymethane and dextran sodium sulfate

21 January 2018

1 reference

Impact of experimental colitis on hepatobiliary transporter expression and bile duct injury in mice.

21 January 2018

1 reference

Efflux transporters in ulcerative colitis: decreased expression of BCRP (ABCG2) and Pgp (ABCB1).

21 January 2018

1 reference

Up-regulation and cytoprotective role of epithelial multidrug resistance-associated protein 1 in inflammatory bowel disease

21 January 2018

1 reference

Leukotrienes: Mediators of Immediate Hypersensitivity Reactions and Inflammation

21 January 2018

1 reference

Multidrug resistance protein (MRP)-mediated transport of leukotriene C4 and chemotherapeutic agents in membrane vesicles. Demonstration of glutathione-dependent vincristine transport

21 January 2018

1 reference

Changes in mRNA expression levels of solute carrier transporters in inflammatory bowel disease patients.

21 January 2018

1 reference

Effects of chronic renal failure on kidney drug transporters and cytochrome P450 in rats

21 January 2018

1 reference

Effect of hemodialysis on hepatic cytochrome P450 functional expression

21 January 2018

1 reference

Effects of serum from patients with chronic renal failure on rat hepatic cytochrome P450

21 January 2018

1 reference

Cytochrome P450 and liver diseases

21 January 2018

1 reference

Down-regulation of hepatic cytochrome p450 in chronic renal failure: role of uremic mediators

21 January 2018

1 reference

Downregulation of intestinal cytochrome p450 in chronic renal failure

21 January 2018

1 reference

Effects of renal failure on drug transport and metabolism

21 January 2018

1 reference

Hepatic drug metabolism and transport in patients with kidney disease.

21 January 2018

1 reference

Emerging evidence of the impact of kidney disease on drug metabolism and transport

21 January 2018

1 reference

Review on uremic toxins: classification, concentration, and interindividual variability

21 January 2018

1 reference

Mechanisms of disease: Cytokine and adipokine signaling in uremic cachexia

21 January 2018

1 reference

Down-regulation of intestinal drug transporters in chronic renal failure in rats.

21 January 2018

1 reference

Down-regulation of rat organic cation transporter rOCT2 by 5/6 nephrectomy

21 January 2018

1 reference

Presumed guilty: natural killer T cell defects and human disease

21 January 2018

1 reference

Glucose-dependent interleukin 6 and tumor necrosis factor production by human peripheral blood monocytes in vitro

21 January 2018

1 reference

Inflammatory cytokine concentrations are acutely increased by hyperglycemia in humans: role of oxidative stress

21 January 2018

1 reference

Obesity is associated with macrophage accumulation in adipose tissue

21 January 2018

1 reference

Adipose expression of tumor necrosis factor-alpha: direct role in obesity-linked insulin resistance

21 January 2018

1 reference

Chronic inflammation in fat plays a crucial role in the development of obesity-related insulin resistance

21 January 2018

1 reference

C-reactive protein, interleukin 6, and risk of developing type 2 diabetes mellitus

21 January 2018

1 reference

Inflammatory cytokines and the risk to develop type 2 diabetes: results of the prospective population-based European Prospective Investigation into Cancer and Nutrition (EPIC)-Potsdam Study

21 January 2018

1 reference

NIDDM as a disease of the innate immune system: association of acute-phase reactants and interleukin-6 with metabolic syndrome X.

21 January 2018

1 reference

Thioredoxin-interacting protein links oxidative stress to inflammasome activation

21 January 2018

1 reference

Glucose-induced beta cell production of IL-1beta contributes to glucotoxicity in human pancreatic islets

21 January 2018

1 reference

Increased number of islet-associated macrophages in type 2 diabetes.

21 January 2018

1 reference

Effect of obesity on the pharmacokinetics of drugs in humans

21 January 2018

1 reference

Pharmacokinetics of drugs in rats with diabetes mellitus induced by alloxan or streptozocin: comparison with those in patients with type I diabetes mellitus.

21 January 2018

1 reference

Increased plasma exposures of five protoberberine alkaloids from Coptidis Rhizoma in streptozotocin-induced diabetic rats: is P-GP involved?

21 January 2018

1 reference

The pharmacokinetics of morphine and its glucuronide conjugate in a rat model of streptozotocin-induced diabetes and the expression of MRP2, MRP3 and UGT2B1 in the liver

21 January 2018

1 reference

The disposition of pravastatin in a rat model of streptozotocin-induced diabetes and organic anion transporting polypeptide 2 and multidrug resistance-associated protein 2 expression in the liver

21 January 2018

1 reference

Impact of acute streptozotocin-induced diabetes on ABC transporter expression in rats

21 January 2018

1 reference

Increased amyloid beta-peptide (1-40) level in brain of streptozotocin-induced diabetic rats

21 January 2018

1 reference

Impaired expression and function of breast cancer resistance protein (Bcrp) in brain cortex of streptozocin-induced diabetic rats

21 January 2018

1 reference

P-glycoprotein-mediated efflux of phenobarbital at the blood-brain barrier evidence from transport experiments in vitro

21 January 2018

1 reference

Attenuated function and expression of P-glycoprotein at blood-brain barrier and increased brain distribution of phenobarbital in streptozotocin-induced diabetic mice.

21 January 2018

1 reference

P-glycoprotein and breast cancer resistance protein expression and function at the blood-brain barrier and blood-cerebrospinal fluid barrier (choroid plexus) in streptozotocin-induced diabetes in rats

21 January 2018

1 reference

Functional induction of P-glycoprotein in the blood-brain barrier of streptozotocin-induced diabetic rats: evidence for the involvement of nuclear factor-kappaB, a nitrosative stress-sensitive transcription factor, in the regulation

21 January 2018

1 reference

Decreased blood-brain barrier permeability to fluorescein in streptozotocin-treated rats.

21 January 2018

1 reference

Change in P-glycoprotein and caveolin protein expression in brain striatum capillaries in New Zealand obese mice with type 2 diabetes

21 January 2018

1 reference

Impaired function and expression of P-glycoprotein in blood-brain barrier of streptozotocin-induced diabetic rats

21 January 2018

1 reference

Insulin therapy restores impaired function and expression of P-glycoprotein in blood-brain barrier of experimental diabetes

21 January 2018

1 reference

Impact of hyperlipidemia on plasma protein binding and hepatic drug transporter and metabolic enzyme regulation in a rat model of gestational diabetes

21 January 2018

1 reference

Increase in P-glycoprotein accompanied by activation of protein kinase Calpha and NF-kappaB p65 in the livers of rats with streptozotocin-induced diabetes.

21 January 2018

1 reference

Inducible nitric oxide synthase-mediated decrease of intestinal P-glycoprotein expression under streptozotocin-induced diabetic conditions

21 January 2018

1 reference

Increased efflux of glutathione conjugate in acutely diabetic cardiomyocytes

21 January 2018

1 reference

Increased expression of the multidrug resistance-associated protein 1 (MRP1) in kidney glomeruli of streptozotocin-induced diabetic rats.

21 January 2018

1 reference

Mechanisms of reduced maternal and fetal lopinavir exposure in a rat model of gestational diabetes.

21 January 2018

1 reference

Regulatory network of lipid-sensing nuclear receptors: roles for CAR, PXR, LXR, and FXR.

21 January 2018

1 reference

Renal and hepatic transporter expression in type 2 diabetic rats

21 January 2018

1 reference

Alteration of hepatic but not renal transporter expression in diet-induced obese mice

21 January 2018

1 reference

Effects of obesity induced by high-fat diet on the pharmacokinetics of nelfinavir, a HIV protease inhibitor, in laboratory rats

21 January 2018

1 reference

Role of high-fat diet in regulation of gene expression of drug metabolizing enzymes and transporters

21 January 2018

1 reference

Drug-metabolizing enzyme and transporter expression in a mouse model of diabetes and obesity.

21 January 2018

1 reference

Experimental rat models to study the metabolic syndrome

21 January 2018

1 reference

Bile secretory function in the obese Zucker rat: evidence of cholestasis and altered canalicular transport function

21 January 2018

1 reference

Characterization of organic anion transporter regulation, glutathione metabolism and bile formation in the obese Zucker rat.

21 January 2018

1 reference

Molecular mechanisms of drug transporter regulation

21 January 2018

1 reference

Bile salt transporters: molecular characterization, function, and regulation

21 January 2018

1 reference

Role of nuclear receptors in the adaptive response to bile acids and cholestasis: pathogenetic and therapeutic considerations.

21 January 2018

1 reference

Adaptive changes in hepatobiliary transporter expression in primary biliary cirrhosis.

21 January 2018

1 reference

Nuclear receptor regulation of the adaptive response of bile acid transporters in cholestasis.

21 January 2018

1 reference

Inflammation and altered drug clearance in cancer: transcriptional repression of a human CYP3A4 transgene in tumor-bearing mice

21 January 2018

1 reference

Inflammation and CYP3A4-mediated drug metabolism in advanced cancer: impact and implications for chemotherapeutic drug dosing

21 January 2018

1 reference

Cellular and molecular pathways linking inflammation and cancer

21 January 2018

1 reference

Inflammation and cancer: causes and consequences

21 January 2018

1 reference

Regulation of drug-metabolizing enzymes and transporters in inflammation

21 January 2018

1 reference

Downregulation of drug transport and metabolism in mice bearing extra-hepatic malignancies

21 January 2018

1 reference

Transcriptional repression of hepatic cytochrome P450 3A4 gene in the presence of cancer.

21 January 2018

1 reference

Extrahepatic cancer suppresses nuclear receptor-regulated drug metabolism

21 January 2018

1 reference

Cancer and inflammation: implications for pharmacology and therapeutics

21 January 2018

1 reference

KLF6 and HSF4 transcriptionally regulate multidrug resistance transporters during inflammation

21 January 2018

1 reference

Regulation of transporters by nuclear hormone receptors: implications during inflammation.

21 January 2018

1 reference

Neuroinflammation activates Mdr1b efflux transport through NFkappaB: promoter analysis in BBB endothelia

21 January 2018

1 reference

The role of cerebral vascular NFkappaB in LPS-induced inflammation: differential regulation of efflux transporter and transporting cytokine receptors

21 January 2018

1 reference

Nuclear receptors: mediators and modifiers of inflammation-induced cholestasis

21 January 2018

1 reference

Endotoxin leads to rapid subcellular re-localization of hepatic RXRalpha: A novel mechanism for reduced hepatic gene expression in inflammation

21 January 2018

1 reference

Redundant roles for cJun-N-terminal kinase 1 and 2 in interleukin-1beta-mediated reduction and modification of murine hepatic nuclear retinoid X receptor alpha

21 January 2018

1 reference

Nuclear export of retinoid X receptor alpha in response to interleukin-1beta-mediated cell signaling: roles for JNK and SER260.

21 January 2018

1 reference

The role of inflammation in cholestasis: clinical and basic aspects

21 January 2018

1 reference

The involvement of the pregnane X receptor in hepatic gene regulation during inflammation in mice

21 January 2018

1 reference

Experimental LPS-induced cholestasis alters subcellular distribution and affects colocalization of Mrp2 and Bsep proteins: a quantitative colocalization study.

21 January 2018

1 reference

Altered localization and activity of canalicular Mrp2 in estradiol-17beta-D-glucuronide-induced cholestasis

21 January 2018

1 reference

Xenobiotic transporters of the human organic anion transporting polypeptides (OATP) family

21 January 2018

1 reference

Hepatic cytochrome P450 down-regulation during aseptic inflammation in the mouse is interleukin 6 dependent

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1586/ECP.11.66

1 reference

26 August 2017

1 reference